BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 31282537)

  • 21. Microenvironment-induced cancer metastasis.
    Rofstad EK
    Int J Radiat Biol; 2000 May; 76(5):589-605. PubMed ID: 10866281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia and Metabolism in Metastasis.
    Zhang T; Suo C; Zheng C; Zhang H
    Adv Exp Med Biol; 2019; 1136():87-95. PubMed ID: 31201718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia-driven intratumor heterogeneity and immune evasion.
    Terry S; Engelsen AST; Buart S; Elsayed WS; Venkatesh GH; Chouaib S
    Cancer Lett; 2020 Nov; 492():1-10. PubMed ID: 32712233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia.
    Bindra RS; Glazer PM
    Oncogene; 2007 Mar; 26(14):2048-57. PubMed ID: 17001309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ever-expanding role of HIF in tumour and stromal biology.
    LaGory EL; Giaccia AJ
    Nat Cell Biol; 2016 Apr; 18(4):356-65. PubMed ID: 27027486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor hypoxia as a modifier of DNA strand break and cross-link repair.
    Chan N; Koch CJ; Bristow RG
    Curr Mol Med; 2009 May; 9(4):401-10. PubMed ID: 19519397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hypoxic tumour microenvironment and metastatic progression.
    Subarsky P; Hill RP
    Clin Exp Metastasis; 2003; 20(3):237-50. PubMed ID: 12741682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human somatic cells deficient for RAD52 are impaired for viral integration and compromised for most aspects of homology-directed repair.
    Kan Y; Batada NN; Hendrickson EA
    DNA Repair (Amst); 2017 Jul; 55():64-75. PubMed ID: 28549257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic instability and cancer.
    Charames GS; Bapat B
    Curr Mol Med; 2003 Nov; 3(7):589-96. PubMed ID: 14601634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting.
    Takeda K; Nakayama M; Hayakawa Y; Kojima Y; Ikeda H; Imai N; Ogasawara K; Okumura K; Thomas DM; Smyth MJ
    Nat Commun; 2017 Feb; 8():14607. PubMed ID: 28233863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of EGFR with the tumour microenvironment: implications for radiation treatment.
    Nijkamp MM; Span PN; Bussink J; Kaanders JH
    Radiother Oncol; 2013 Jul; 108(1):17-23. PubMed ID: 23746695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nickel induces transcriptional down-regulation of DNA repair pathways in tumorigenic and non-tumorigenic lung cells.
    Scanlon SE; Scanlon CD; Hegan DC; Sulkowski PL; Glazer PM
    Carcinogenesis; 2017 Jun; 38(6):627-637. PubMed ID: 28472268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrations in DNA repair pathways in cancer and therapeutic significances.
    Motegi A; Masutani M; Yoshioka KI; Bessho T
    Semin Cancer Biol; 2019 Oct; 58():29-46. PubMed ID: 30922960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The growing complexity of HIF-1α's role in tumorigenesis: DNA repair and beyond.
    Rohwer N; Zasada C; Kempa S; Cramer T
    Oncogene; 2013 Aug; 32(31):3569-76. PubMed ID: 23160373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA double-strand-break repair in higher eukaryotes and its role in genomic instability and cancer: Cell cycle and proliferation-dependent regulation.
    Mladenov E; Magin S; Soni A; Iliakis G
    Semin Cancer Biol; 2016 Jun; 37-38():51-64. PubMed ID: 27016036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased levels of RECQ5 shift DNA repair from canonical to alternative pathways.
    Olson HC; Davis L; Kiianitsa K; Khoo KJ; Liu Y; Knijnenburg TA; Maizels N
    Nucleic Acids Res; 2018 Oct; 46(18):9496-9509. PubMed ID: 30107528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia provokes base excision repair changes and a repair-deficient, mutator phenotype in colorectal cancer cells.
    Chan N; Ali M; McCallum GP; Kumareswaran R; Koritzinsky M; Wouters BG; Wells PG; Gallinger S; Bristow RG
    Mol Cancer Res; 2014 Oct; 12(10):1407-15. PubMed ID: 25030372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic lethality in DNA repair network: A novel avenue in targeted cancer therapy and combination therapeutics.
    Bhattacharjee S; Nandi S
    IUBMB Life; 2017 Dec; 69(12):929-937. PubMed ID: 29171189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional landscape of DNA repair genes underpins a pan-cancer prognostic signature associated with cell cycle dysregulation and tumor hypoxia.
    Chang WH; Lai AG
    DNA Repair (Amst); 2019 Jun; 78():142-153. PubMed ID: 31054516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia and the Tumor Secretome.
    Liu Y; Ciotti GE; Eisinger-Mathason TSK
    Adv Exp Med Biol; 2019; 1136():57-69. PubMed ID: 31201716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.